Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Furthering cell therapy ambition across oncology and autoimmune diseases
US FDA approval based on NEURO-TTRansform Phase III results
Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
World HRD Congress is a well-known international body of Management Studies
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Subscribe To Our Newsletter & Stay Updated
